Abiopharma

Compass Pathways - Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Rosen Law Firm Encourages Green Circle Decarbonize Technology Ltd. Investors to Inquire About Securities Class Action Investigation – GCDT

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026

Meet the SWE Entrepreneurs Affinity Group Leadership Team — Part 1

ENPH Deadline: Rosen Law Firm Urges Enphase Energy, Inc. (NASDAQ: ENPH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases

Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Phase 4 Study

Kaskela Law Firm Announces Stockholder Investigation of HF Foods Group Inc. (HFFG) and Encourages HFFG Shareholders with Investment Losses to Contact the Firm